Baidu
map

这9种药一定要做过敏试验!

2016-05-04 阿米 医路有我

过敏反应严重时,可危及生命。药造成的过敏可瞬间致人死亡。常用药品中,有些会导致严重的过敏性休克,医生谨慎,患者也要有强烈的意识。下面9种注射类过敏性药物,使用前一定要做过敏试验。   1、青霉素类 使用前必须做过敏试验 过去用过没过敏,停用后再用仍要做皮试 并非皮试阴性就一定不发生过敏反应 使用后要在用药现场观察0.5-1小时再离开   2、头孢菌素类

过敏反应严重时,可危及生命。药造成的过敏可瞬间致人死亡。常用药品中,有些会导致严重的过敏性休克,医生谨慎,患者也要有强烈的意识。下面9种注射类过敏性药物,使用前一定要做过敏试验。
 
1、青霉素类

使用前必须做过敏试验
过去用过没过敏,停用后再用仍要做皮试
并非皮试阴性就一定不发生过敏反应
使用后要在用药现场观察0.5-1小时再离开
 
2、头孢菌素类

青霉素皮试阳性,若改选头孢类,仍要做头孢类皮试,若阳性不可用
青霉素皮试阴性,可直接选用头孢类
 
3、链霉素过敏性休克死亡率高,用前必须做皮试
 
4、破伤风抗毒素

必须做过敏试验

一旦发生,极易出现休克,严重时可迅速死亡
 
5、盐酸普鲁卡因

局麻药
有潜在过敏性,用前皮试
 
6、门冬酰胺酶

抗肿瘤药,约 3% 的患者发生过敏性休克
皮试阴性者也可发生过敏反应,用药前须备有抗过敏药
 
7、胸腺肽

细胞免疫调节剂
对于过敏体质者,需做皮试
 
8、降钙素易发生过敏反应,使用前应做皮肤过敏试验
 
9、注射维生素 B1 

偶见过敏反应
少用注射剂,可用口服
 
10、关于皮肤敏感试验

皮试后观察 15-20 分钟
阴性——皮试局部无红肿,无自觉症状
阳性——皮试局部隆起,出现红晕,硬块,痒感
严重时全身出现皮疹或过敏性休克反应
有家族过敏史、有药品过敏史者应高度警惕
即使皮试阴性,用药后仍需观察0.5-1小时离开

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=85591, encodeId=4bc385591d7, content=好好学习,积极应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Thu May 12 11:39:00 CST 2016, time=2016-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84322, encodeId=74ad84322f2, content=学习了,以后注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 05 20:27:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84208, encodeId=7ac18420840, content=我都没有做过,下次一定要注意了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160429/IMG5723731439C3A8303.jpg, createdBy=a6d41719037, createdName=金色蝴蝶, createdTime=Wed May 04 15:58:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84196, encodeId=f56d8419654, content=学习啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed May 04 14:46:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83939, encodeId=85d1839399c, content=ok??, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Wed May 04 12:19:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83929, encodeId=3dfd839299b, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Wed May 04 11:29:00 CST 2016, time=2016-05-04, status=1, ipAttribution=)]
    2016-05-12 QQ6709219e

    好好学习,积极应用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=85591, encodeId=4bc385591d7, content=好好学习,积极应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Thu May 12 11:39:00 CST 2016, time=2016-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84322, encodeId=74ad84322f2, content=学习了,以后注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 05 20:27:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84208, encodeId=7ac18420840, content=我都没有做过,下次一定要注意了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160429/IMG5723731439C3A8303.jpg, createdBy=a6d41719037, createdName=金色蝴蝶, createdTime=Wed May 04 15:58:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84196, encodeId=f56d8419654, content=学习啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed May 04 14:46:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83939, encodeId=85d1839399c, content=ok??, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Wed May 04 12:19:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83929, encodeId=3dfd839299b, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Wed May 04 11:29:00 CST 2016, time=2016-05-04, status=1, ipAttribution=)]
    2016-05-05 明崖

    学习了,以后注意

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=85591, encodeId=4bc385591d7, content=好好学习,积极应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Thu May 12 11:39:00 CST 2016, time=2016-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84322, encodeId=74ad84322f2, content=学习了,以后注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 05 20:27:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84208, encodeId=7ac18420840, content=我都没有做过,下次一定要注意了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160429/IMG5723731439C3A8303.jpg, createdBy=a6d41719037, createdName=金色蝴蝶, createdTime=Wed May 04 15:58:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84196, encodeId=f56d8419654, content=学习啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed May 04 14:46:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83939, encodeId=85d1839399c, content=ok??, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Wed May 04 12:19:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83929, encodeId=3dfd839299b, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Wed May 04 11:29:00 CST 2016, time=2016-05-04, status=1, ipAttribution=)]
    2016-05-04 金色蝴蝶

    我都没有做过,下次一定要注意了。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=85591, encodeId=4bc385591d7, content=好好学习,积极应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Thu May 12 11:39:00 CST 2016, time=2016-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84322, encodeId=74ad84322f2, content=学习了,以后注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 05 20:27:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84208, encodeId=7ac18420840, content=我都没有做过,下次一定要注意了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160429/IMG5723731439C3A8303.jpg, createdBy=a6d41719037, createdName=金色蝴蝶, createdTime=Wed May 04 15:58:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84196, encodeId=f56d8419654, content=学习啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed May 04 14:46:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83939, encodeId=85d1839399c, content=ok??, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Wed May 04 12:19:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83929, encodeId=3dfd839299b, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Wed May 04 11:29:00 CST 2016, time=2016-05-04, status=1, ipAttribution=)]
    2016-05-04 1dd8c52fm63(暂无匿称)

    学习啦!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=85591, encodeId=4bc385591d7, content=好好学习,积极应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Thu May 12 11:39:00 CST 2016, time=2016-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84322, encodeId=74ad84322f2, content=学习了,以后注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 05 20:27:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84208, encodeId=7ac18420840, content=我都没有做过,下次一定要注意了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160429/IMG5723731439C3A8303.jpg, createdBy=a6d41719037, createdName=金色蝴蝶, createdTime=Wed May 04 15:58:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84196, encodeId=f56d8419654, content=学习啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed May 04 14:46:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83939, encodeId=85d1839399c, content=ok??, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Wed May 04 12:19:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83929, encodeId=3dfd839299b, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Wed May 04 11:29:00 CST 2016, time=2016-05-04, status=1, ipAttribution=)]
    2016-05-04 lyh994

    ok??

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=85591, encodeId=4bc385591d7, content=好好学习,积极应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Thu May 12 11:39:00 CST 2016, time=2016-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84322, encodeId=74ad84322f2, content=学习了,以后注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 05 20:27:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84208, encodeId=7ac18420840, content=我都没有做过,下次一定要注意了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160429/IMG5723731439C3A8303.jpg, createdBy=a6d41719037, createdName=金色蝴蝶, createdTime=Wed May 04 15:58:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84196, encodeId=f56d8419654, content=学习啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed May 04 14:46:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83939, encodeId=85d1839399c, content=ok??, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Wed May 04 12:19:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83929, encodeId=3dfd839299b, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Wed May 04 11:29:00 CST 2016, time=2016-05-04, status=1, ipAttribution=)]
    2016-05-04 收获你的美

    不错,学习了

    0

相关资讯

Nature:引发药物过敏反应的关键受体MRGPRX2被发现

英国《自然》杂志网站17日刊登一项研究成果,科研人员通过动物实验发现,在一种免疫细胞表面附着的蛋白质受体是引发药物过敏反应的“开关”,去除这种蛋白质可有效预防此类过敏症状。一些人在注射或口服某些药物后,会发生一系列过敏样反应,比如出现皮疹、全身性过敏反应、血压和心率变化等。此前研究发现,这类反应与一种被称为“肥大细胞”的免疫细胞有关,这种细胞存在于许多人体组织中。但其具体反应机制尚不清楚。美国约翰

Allergy:全欧洲范围内的过敏反应数据分析

各国之间严重过敏反应的发生率、诱发因素和治疗之间存在不同。2014年10月,发表在 Allergy 的一项研究对10个欧洲国家涉及诊断和咨询过敏反应的标准化数据进行分析。该研究首次提供了全欧洲范围内的过敏反应数据,证实了该试验阶段研究潜在的功能性,并允许对相关中心和国家间的症状形式、诱发因素和治疗习惯进行比较。背景:我们已经认识到各国之间严重过敏反应的发生率、诱发因素和治疗之间存在不同。我们旨在选

Baidu
map
Baidu
map
Baidu
map